IVVD FY 2024 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena

IVVDInvivyd, Inc.

$257M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$25M

Gross Profit

$24M93.6% margin

Operating Income

-$177M-696.8% margin

Net Income

-$170M-669.4% margin

EPS (Diluted)

$-1.43

Cash Flow

Operating Cash Flow

-$170M

Free Cash Flow

-$171M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$130M

Total Liabilities

$62M

Stockholders' Equity

$68M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$0	—
Gross Profit	$24M	$0	—
Operating Income	-$177M	-$213M	+16.9%
Net Income	-$170M	-$199M	+14.5%